Hospital Universitario HM Montepríncipe
Boadilla Del Monte, Madrid, Spain
General hospital in Spain
Av. de Montepríncipe, 25, 28660 Boadilla del Monte, Madrid
About Hospital Universitario HM Montepríncipe
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital Universitario HM Montepríncipe
During the past decade, Hospital Universitario HM Montepríncipe conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on
average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer
2013-06-12
2023-03-31
Active, not recruiting
118
Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
2013-12-13
2023-03-31
Active, not recruiting
247
A Multicenter Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain
2012-05-01
2014-07-01
Terminated
231
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
2015-11-22
2024-04-30
Recruiting
250
Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide
2015-09-01
2017-02-01
Terminated
13
The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice
2016-02-01
2016-10-01
Terminated
31
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
2001-03-01
2027-12-01
Recruiting
120,000
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
2019-03-26
2023-06-01
Recruiting
1,088
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Universitario HM Montepríncipe" #1 sponsor was "Pfizer" with 4 trials, followed by "PharmaMar" with 3 trials
sponsored, "BioNTech SE" with 2 trials sponsored, "Bama GeVe, S.L.U." with 1 trials sponsored and "Biomendi S.A.U."
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario HM Montepríncipe"
#1 collaborator was "Pfizer" with 3 trials as a collaborator, "Apices Soluciones S.L." with 2 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Hospital Universitario HM Montepríncipe
According to Clinical.Site data, the most researched conditions in "Hospital Universitario HM Montepríncipe" are
"COVID-19" (2 trials), "COVID-19 Infection" (2 trials), "Pneumococcal Disease" (2 trials), "Venous Thromboembolism" (2 trials) and "Advanced, Androgen Receptor Positive Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital Universitario HM Montepríncipe" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario HM Montepríncipe
Most popular intervention types in "Hospital Universitario HM Montepríncipe" are "Drug" (10 trials), "Biological" (4 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "13-valent pneumococcal conjugate vaccine" (2 trials), "20-valent pneumococcal conjugate vaccine" (2 trials), "Enzalutamide" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario HM Montepríncipe
The vast majority of trials in "Hospital Universitario HM Montepríncipe" are
14 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hospital Universitario HM Montepríncipe
Currently, there are NaN active trials in "Hospital Universitario HM Montepríncipe".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital Universitario HM Montepríncipe,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario HM Montepríncipe, 2 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".